Granules India Stock

Granules India Limited engages in the production of active pharmaceutical ingredients (APIs) and pharmaceutical formulation intermediates (PFI).

Division

API division

The company’s API facilities are located at Jeedimetla and Bonthapally. The Jeedimetla unit manufactures APIs like metformin, methocarbamol, guaifenesin, and phenazopyridine, whereas the Bonthapally unit manufactures APIs like paracetamol or acetaminophen.

PFI division

The company’s PFI facilities are located at Jeedimetla and Gagillapur. It manufactures combination PFIs using multiple APIs.

Formulations division

The company has a tablet facility at Gagillapur with an annual capacity of six billion tablets.

Markets

The company sells its products in India, the United States, Canada, Latin America, Europe, and the Asia Pacific.

Joint Ventures

The company has a joint venture with Hubei Biocause Heilen Pharmaceutical Co. to manufacture ibuprofen in China.

History

Granules India Limited was founded in 1984.